Rasmussen’s encephalitis: update on pathogenesis and treatment

References

• Aarli JA. Immunological aspects of epilepsy. Brain Dev. 15,41–50 (1993).
   PubMed Web of Science ®Google Scholar
• Barker CF, Billingham RE. Immunologically privileged sites. Adv. Immunol 25,1–54 (1977).
   PubMed Web of Science ®Google Scholar
• Wekerle H, Linington C, Lassmann H, Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 9, 271–277 (1986).
   Web of Science ®Google Scholar
• Seabrook TJ, Johnston M, Hay JB. Cerebral spinal fluid lymphocytes are part of the normal recirculating lymphocyte pool. J. Neuroimmunol 91,100–107 (1998).
   Google Scholar
• Brabb T, von Dassow P, Ordonez N, Schnabel B, Duke B, Goverman J. In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J. Exp. Med. 192,871–880 (2000).
   PubMed Web of Science ®Google Scholar
• Hart Y, Andermann F. Rasmussen syndrome. In: Intractable Focal Epilepsy Oxbury JM, Polkey CE, Duchowny M (Eds). WB Saunders, London, UK, 233–248 (2000).
   Google Scholar
• Hart YM, Andermann F, Fish DR et al Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen's syndrome? Neurology 48, 418–424 (1997).
   PubMed Web of Science ®Google Scholar
• Leach JP, Chadwick DW, Miles JB, Hart IK. Improvement in adult onset Rasmussen's encephalitis with long-term immunomodulatory therapy. Neurology52, 738–742 (1999).
   PubMed Web of Science ®Google Scholar
• Villani F, SpreafIco R, Farina L eta! Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis. Neurology 56, 248–250 (2001).
   PubMed Web of Science ®Google Scholar
• Vadlamudi L, Galion CJ, Jeavons SJ et al. Rasmussen's syndrome in a 54 year old female: more support for an adult variant. J. Clin. Neurosci. 7,154-156 (2000).
   Google Scholar
• Granata T, Spreafico R, Gobbi G eta! Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 60,422-425 (2003). Useful report on the clinical features allowing early diagnosis of Rasmussen's encephalitis (RE).
   Google Scholar
• Bien CG, Widman G, Urbach H eta! The natural history of Rasmussen's encephalitis. Brain 125,1751-1759 (2002). First paper covering the clinical natural history of RE with particular reference to the time course of brain destruction and for the evaluation of prognosis in disease.
   Google Scholar
• Oguni H, Andermann F, Rasmussen TB. The natural history of the syndrome of chronic encephalitis and epilepsy: a study of the MNI series of forty-eight cases. In: Chronic Encephalitis and Epilepsy: Rasmussen's Syndrome. Andermann F (Ed.). Butterworth-Heinemann, Boston, MA, USA, 7–35 (1991).
   Google Scholar
• Tampieri D, Melanson D, Ethier R. Imaging of chronic encephalitis. In Chronic Encephalitis and Epilepsy: Rasmussen Syndrome. Andermann F (Ed.). Butterworth-Heinemann, Boston, MA, USA, 47–60 (1991).
   Google Scholar
• Chiapparini L, Granata T, Farina L eta! Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis? Neurology 45, 171–183 (2003).
   Google Scholar
• Bien CG, Urbach H, Deckert Metal Diagnosis and staging of Rasmusseris encephalitis by serial MRI and histopathology. Ainrology58, 250–257 (2002).
   Google Scholar
• Rasmussen T, Olszewski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology8, 435–445 (1958).
   Google Scholar
• Farrell MA, Droogan O, Secor DL, Poukens V, Quinn B, Vinters HV. Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol 89,313–321 (1995).
   PubMed Web of Science ®Google Scholar
• Robitaille Y. Neuropathologic aspects of chronic encephalitis. In: Chronic Encephalitis and Epilepsy: Rasmussen Syndrome. Andermann F (Ed.). Butterworth-Heinemann, Boston, MA, USA, 89–110 (1991).
   Google Scholar
• Andermann F, Hart Y. Rasmussen's syndrome. In: Textbook of Neumlogy Neurobase. International League Against Epilepsy (Ed.). Arbor Press, MI, USA (2003).
   Google Scholar
• Friedman H, Chien L, Parham D. Virus in brain of child with hemiplegia, hemiconvulsions and epilepsy. Lancet 2, 666 (1977).
   PubMedGoogle Scholar
• Walter GF, Renella RR. Epstein-Barr virus in brain and Rasmussen's encephalitis. Lancet 1,279–280 (1989).
   PubMed Web of Science ®Google Scholar
• Power C, Poland SD, Blume WT, Girvin JP, Rice GP Cytomegalovirus and Rasmussen's encephalitis. Lancet 336, 1282–1284 (1990).
   PubMed Web of Science ®Google Scholar
• McLachlan RS, Girvin JP, Blume WT, Reichman H. Rasmussen's chronic encephalitis in adults. Azrh. Neural. 50, 269–274 (1993).
   Google Scholar
• Jay V, Becker LE, Otsubo H eta! Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex virus 1 by the polymerase chain reaction and in situ hybridization. Neurology45,108–117 (1995).
   PubMed Web of Science ®Google Scholar
• Rasmussen T Further observations on the syndrome of chronic encephalitis and epilepsy. Appl. Neumphysiol 41,1–12 (1978).
   Google Scholar
• Mizuno Y, Chou SM, Estes ML, Erenberg G, Cruse RE Rothner AD. Chronic localized encephalitis (Rasmussen's) with focal cerebral seizures revisited. J. Neuropathol Exp. Neural. 44, 351 (1985).
   Google Scholar
• Asher DM, Gajdusek DC. Virologic studies in chronic encephalitis. In: Chronic Encephalitis and Epilepsy' Rasmussen's Syndrome. Andermann F (Ed.). Butterworth-Heinemann, Boston, MA, USA, 147–158 (1991).
   Google Scholar
• Paas Y. The macro- and microarchitectures of the ligand-binding domain of glutamate receptors. Trends Neumsci. 21,117–125 (1998).
   PubMed Web of Science ®Google Scholar
• Rogers SW, Andrews PI, Gahring LC eta! Autoantibodies to glutamate receptor G1uR3 in Rasmussen's encephalitis. Science 265,648–651 (1994).
   PubMed Web of Science ®Google Scholar
• LuR3 is a key pathogenetic mechanism in the disease.
   Google Scholar
• Antozzi C, Granata T, Aurisano N eta! Long-term selective IgG immunoadsorption improves Rasmussen's encephalitis. Neurology51,302–305 (1998).
   PubMed Web of Science ®Google Scholar
• •The use of protein A imrnunoadsorption allowed us to identify, in the imrnunoglobulin G fraction, a critical compartment the removal of which induced a significant reduction of seizures frequency and neurological deficits, thus reinforcing the concept of immune-mediated mechanism in RE.
   Google Scholar
• Krauss GL, Campbell ML, Roche KW, Huganir RL, Niedermeyer E. Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor G1uR3. Neumlogy46,247–249 (1996).
   Google Scholar
• Mantegazza R, Bemasconi P, Baggi F eta]. Antibodies against G1uR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. Neumimmunal 131,179–185 (2002).
   Google Scholar
• antibody presence in a large cohort of epileptic patients indicating that these antibodies are not specific for RE and identified another subgroup of epileptic patients, characterized by a catastrophic clinical evolution, that is highly positive for antiGluR3 antibodies.
   Google Scholar
• Wiendl H, Bien CG, Bemasconi P eta]. G1uR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neumlogy57,1511–1514 (2001).
   Google Scholar
• Frassoni C, Spreafico R, Franceschetti S eta! Labeling of rat neurons by antiGluR3 IgG from patients with Rasmussen's encephalitis. Neumlogy57, 324–327 (2001).
   PubMedGoogle Scholar
• Bemasconi P, Cipelletti B, Passerini L eta! Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients' sera. Neurology59, 1998–2001 (2002).
   PubMed Web of Science ®Google Scholar
• Baranzini SE, Laxer K, Saketkhoo R et al Analysis of antibody gene rearrangement, usage and specificity in chronic focal encephalitis. Neumlogy58,709–716 (2002).
   PubMed Web of Science ®Google Scholar
• Twyman RE, Gahring LC, Spless C, Rogers SW Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14,755–762 (1995).
   PubMed Web of Science ®Google Scholar
• He XP, Patel M, Whitney KD, Janumpalli S, Tenner A, McNamara JO. Glutamate receptor G1uR3 antibodies and death of cortical cells. Neuron 20,153–163 (1998).
   PubMed Web of Science ®Google Scholar
• Levite M, Fleidervish IA, Schwarz A eta! Autoantibodies to the glutamate receptor kill neurons via activation of receptor ion channel. Autoimmun. 13,61–72 (1999).
   Web of Science ®Google Scholar
• Carlson NG, Gahring LC, Twyman RE, Rogers SW Identification of amino acids in the glutamate receptor, G1uR3, important for antibody-binding and receptor-specific activation. J. Biol. Chem. 272, 11295–11301 (1997).
   Google Scholar
• Whitney KD, Andrews PI, McNamara JO. Immunoglobulin G and complement immunoreactivity in the cerebral cortex of patients with Rasmussen's encephalitis. Neurology 53, 699–708 (1999).
   Google Scholar
• Whitney KD, McNamara JO. G1uR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. I Neurosci. 20,7307–7316 (2000).
   Google Scholar
• Xiong Z-Q, Oian W, Suzuki K, McNamara JO. Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. j Neurosci. 23, 955–960 (2003).
   Google Scholar
• Yang R, Puranam RS, Butler LS et al. Autoimmunity to Munc-18 in Rasmussen's encephalitis. Neuron 28, 375–383 (2000).
   PubMed Web of Science ®Google Scholar
• Hata Y, Slaughter CA, Sudhof TC. Synaptic vesicle fusion complex contains unc-18 homologue bound to syntaxin. Nature 366,347–351 (1993).
   Google Scholar
• Li Y, Uccelli A, Laxer KD et al. Local- clonal expansion of infiltrating T-lymphocytes in chronic encephalitis of Rasmussen. J. Immunal 158, 1428–1437 (1997).
   PubMed Web of Science ®Google Scholar
• Bien CG, Bauer J, Deckwerth TL eta! Destruction of neurons by cytotoxic T-cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann. Neural. 51, 311–318 (2002).
   PubMed Web of Science ®Google Scholar
• ••Paper is of extreme interest because itdemonstrates that in RE the first step in neurone degeneration is mediated by cytotoxic T-lymphocytes and that this event precedes the autoantibody attack.
   Google Scholar
• Lieberman J. The ABCs of granule- mediated cytotoxicity: new weapons in the arsenal. Nat. Rev Immunal 3,361–370 (2003)
   PubMed Web of Science ®Google Scholar
• Gahring LC, Carlson NG, Meyer EL, Rogers SW Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. j Immunal 166,1433–1438 (2001).
   PubMed Web of Science ®Google Scholar
• Baranzini SE, Laxer K, Bollen A, Oksenberg JR. Gene expression analysis reveals altered brain transcription of glutamate receptors and inflammatory genes in a patient with chronic focal (Rasmussen's) encephalitis. Neumiminunal 128,9-15 (2002). A new molecular approach for the analysis of altered brain tissues from RE patients, showing upregulation of inflammation-related genes and downregulation of several GluRs.
   Google Scholar
• Villemure J-G. Hemispherectomy techniques: a critical review. In: Paediatric Epilepsy Syndromes and their Surgical Treatment. Tuxhorn I, Holthausen H, Boenigk H (Eds). John Libbey, London, UK, 729–738 (1997).
   Google Scholar
• Villemure J-G, Mascott CR. Pen-insular hemispherotomy: surgical principles and anatomy. Neurosurgery37, 975–980 (1995).
   PubMed Web of Science ®Google Scholar
• Devlin AM, Cross JH, Harkness W et al Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescence. Brain 126,556–566 (2003).
   PubMed Web of Science ®Google Scholar
• Schramm J, Kral T, Clusmann H. Transsylvian keyhole functional hemispherectomy. Neurosurgery49, 891–900 (2001).
   PubMed Web of Science ®Google Scholar
• Delalande 0, Pinard JM, Basevant C, Gauthe M, Plouin P, Dulac O. Hemispherotomy: A new procedure for central disconnection. Epilepsia 33 (Suppl. 3), 99–100 (1992).
   Google Scholar
• Chinchilla D, Dulac 0, Robain 0 et al Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids. J. Neural. Neurosurg. Psychiatry 57,1325–1333 (1994).
   Google Scholar
• Hart YM, Cortez M, Andermann F eta]. Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neumlogy 44,1030–1036 (1994).
   Google Scholar
• •A large experience on RE patients treated by corticosteroids and intravenous imrnunoglobulins.
   Google Scholar
• Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO. Plasmapheresis in Rasmussen's encephalitis. Neurology46,242–246 (1996).
   Google Scholar
• Walsh PJ. Treatment of Rasmusseris syndrome with intravenous gammaglobulin. In: Chronic Encephalitis anc101ilepsy: Rasmusseds SyncharrE. Andermann F (Ed.). Butterworth-Heinemann, Boston, MA, USA, 201–204 (1991).
   Google Scholar
• Wise MS, Rutledge SL, Kuzniecky RI. Rasmussen's syndrome and long-term response to gamma globulin. Pal Neural. 14,149–152 (1996).
   Google Scholar
• Granata T, Fusco L, Gobbi G eta]. Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology (2003) (In Press).
   Google Scholar